Skip to main content
Clinical Trials/NCT05093803
NCT05093803
Completed
Not Applicable

Study of Physical and Physiological Changes Through the Use of a Mobile App That Promotes Healthy Habits

University of Alicante1 site in 1 country70 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
University of Alicante
Enrollment
70
Locations
1
Primary Endpoint
CHOLESTEROL
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To investigate the health effects of a new mobile application (app) for prevention and personalized treatment in people with chronic cardiovascular pathologies associated with body composition.

Detailed Description

Scientific evidence has shown that the adoption of the Mediterranean diet is a protective factor against the appearance of several types of cancer, cardiovascular diseases, aging and obesity due to the amount of nutrients with anti-cancer, anti-inflammatory and anti-obesity properties that jointly contribute to the maintenance of health status. The antitumor effects of the Mediterranean diet are mainly due to the combination of antioxidant elements, fiber and polyunsaturated fats. Therefore, this dietary pattern is essential as a preventive measure against the onset of cancer and other chronic diseases, but also to reduce health care costs. Monitoring physical activity should be considered as a central factor when addressing precision nutrition. Perform physical activity and exercise, as they are key components of energy expenditure and balance, in addition, structural changes occur in muscles, increase in the number of mitochondria in fiber, secretion of metabolically beneficial hormones with reversal of muscle insulin resistance and reduction of hepatic lipogenesis. Regardless of intensity, short-term exercise has been shown to improve adiposity and insulin sensitivity, which may help reduce metabolic risk. Boutcher et al. also demonstrated that intermittent aerobic and anaerobic exercise performed at an intensity \>70% of maximal oxygen uptake significantly reduces ambulatory and office blood pressure in hypertensive individuals. The development of this app aims, through self-management and visualizing the altered parameters and how they will evolve in your body in the short, medium and long term, to increase the population's commitment to these pathologies, in order to improve their health.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
December 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Alejandro Martínez-Rodríguez

Assistant Professor

University of Alicante

Eligibility Criteria

Inclusion Criteria

  • Men and women over 21 years of age

Exclusion Criteria

  • Volunteers who do not have access to a smartphone.

Outcomes

Primary Outcomes

CHOLESTEROL

Time Frame: 24 months

The blood cholesterol level is obtained through a blood test.

BLOOD PREASURE

Time Frame: 24 months

Measurement of blood pressure (systolic and diastolic) with a digital tensiometer.

Ultrasonic wave propagation speed, SOS

Time Frame: 24 months

The measurement of ultrasonic wave propagation speed (SOS) by the traversed bone tissue (calcaneus) is performed using the GE Achilles Insight device.

WEIGHT WEIGHT WEIGHT WEIGHT WEIGHT

Time Frame: 24 months

The weight of the subjects will be obtained using the TANITA (Tokyo, Japan).

HEIGHT

Time Frame: 24 months

The height of the subjects will be measured with the SECA 123 stadiometer (Hamburg, Germany).

WAIST CIRCUMFERENCE

Time Frame: 24 months

The kinanthropometric evaluation is based on the methodology proposed for the restricted profile by the International Society for the Development of Kinanthropometry (ISAK). The material used to measure the perimeters will be a tape.

FAT MASS

Time Frame: 24 months

Assessment of body composition using the TANITA (Tokyo, Japan) validated bioimpedance scale to obtain the results of fat mass.

TROPONIN I

Time Frame: 24 months

The troponin I level is obtained through a blood test.

BLOOD TROPONIN T LEVELS

Time Frame: 24 months

The troponin I level is obtained through a blood test.

HIP CIRCUMFERENCE

Time Frame: 24 months

The kinanthropometric evaluation is based on the methodology proposed for the restricted profile by the International Society for the Development of Kinanthropometry (ISAK). The material used to measure the perimeters will be a tape.

TRIGLICERIDES

Time Frame: 24 months

The blood triglicerides level is obtained through a blood test.

LEAN BODY MASS

Time Frame: 24 months

Assessment of body composition using the TANITA (Tokyo, Japan) validated bioimpedance scale to obtain the results of lean body mass.

VISCERAL FAT

Time Frame: 24 months

Assessment of body composition using the TANITA (Tokyo, Japan) validated bioimpedance scale to obtain the results of visceral fat.

HEART RATE

Time Frame: 24 months

Heart rate measurement is performed with an activity wristband.

Broadband ultrasonic attenuation, BUA

Time Frame: 24 months

The measurement of the ultrasonic band attenuation (BUA) by the traversed bone tissue (calcaneus) is performed using the GE Achilles Insight device.

Study Sites (1)

Loading locations...

Similar Trials